Correspondence on: ‘Dupilumab as a novel steroid-sparing treatment for IgG4-related disease’ by Simpson et al | Annals of the Rheumatic Diseases

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Correspondence

Correspondence on: ‘Dupilumab as a novel steroid-sparing treatment for IgG₄-related disease’ by Simpson et al

Free

Online download statistics by month:

Online download statistics by month: January 2020 to April 2022

	Abstract	Full	Pdf
Jan 2020	145	141	13
Feb 2020	469	462	74
Mar 2020	180	176	18
Apr 2020	44	40	8
May 2020	39	34	12
Jun 2020	26	31	7
Jul 2020	34	33	13
Aug 2020	29	29	20
Sep 2020	25	22	15
Oct 2020	28	25	9
Nov 2020	11	10	9
Dec 2020	9	9	7
Jan 2021	32	28	20
Feb 2021	20	20	11
Mar 2021	22	22	16
Apr 2021	29	27	13
May 2021	69	67	20
Jun 2021	20	18	6
Jul 2021	36	34	10
Aug 2021	24	21	4
Sep 2021	22	21	17
Oct 2021	29	28	27
Nov 2021	43	42	23
Dec 2021	130	129	11
Jan 2022	350	352	29
Feb 2022	150	145	23
Mar 2022	57	55	26
Apr 2022	69	64	23
Total	2141	2085	484